Safety Rates Drug Report: Bevacizumab Blood alkaline phosphatase increased adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: Bevacizumab Injury: Blood alkaline phosphatase increased Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 10 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
122936806	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	79.00 YR	F	83 KG	20160915	US
125353363	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	63.00 YR	M	78 KG	20160926	US
126426821	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	70.00 YR	M	58 KG	20160810	FR
127139511	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	71.00 YR	F	69 KG	20160905	US
127413061	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	56.00 YR	F	48 KG	20160914	US
127448851	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	61.00 YR	F	64 KG	20160915	US
127904201	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	57.00 YR	F	129 KG	20160929	US
127975001	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	68.70 YR	F	0	20160930	US
127977921	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	55.00 YR	F	76 KG	20160930	US
127986121	Bevacizumab	Blood alkaline phosphatase increased	ROCHE	62.00 YR	F	72 KG	20160930	US

|< 1/2 << Previous Page Page 1

Total Records: 10 Number of Pages: 1

Execution Time: 0.035027980804443 seconds (ucode:5118122). Developed by: James D. Barger